Obstetrics & Gynecology Doctors in Delano, CA Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Rhonda Robinson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1508 Garces Hwy Ste 1, Delano, CA 93215 Phone: 661-725-4780    Fax: 661-725-1048

Dr. Jesus Pulido Baldonado, M.D. Obstetrics & Gynecology - Gynecology Medicare: Medicare Enrolled Practice Location: 1201 Jefferson St, Delano, CA 93215 Phone: 661-721-0737    Fax: 661-721-0738

Dr. Babita Datta, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1401 Garces Hwy, Delano, CA 93215 Phone: 661-792-7333

Toni-ann Lewis, NP Obstetrics & Gynecology - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 323 S Lexington St, Delano, CA 93215 Phone: 661-725-2512    Fax: 661-725-2586

Debbie Ann Marie Dennis, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1201 Jefferson St, Delano, CA 93215 Phone: 661-721-0737    Fax: 661-721-0738

Lydia Soriano Zapanta, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1619 Cecil Ave, Delano, CA 93215 Phone: 661-725-6265    Fax: 661-725-2899

News Archive

Studying sensory neurons could provide new insights to treat ALS

Virginia Tech Carilion Research Institute scientists have shown that mutations in specific genes that destroy motor neurons and thereby cause the devastating effects of amyotrophic lateral sclerosis- also known as ALS or Lou Gehrig's disease - also attack sensory neurons.

A quarter of men could safely avoid prostate biopsy if MRI is used

Performing an MRI scan of men with suspected prostate cancer could spare a quarter of men from having to undergo prostate biopsy, according to a study published in The Lancet.

Researchers eliminate need for anti-rejection drugs in mice with transplanted glial cells

In experiments in mice, Johns Hopkins Medicine researchers say they have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.

VentiRx presents VTX-2337 Phase 1 trial results against advanced solid tumors at ASCO 2011

VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 agonists for the treatment of cancer, respiratory and autoimmune diseases, today announced the presentation of results from a Phase 1 clinical trial of VTX-2337, a selective TLR8 agonist in patients with advanced solid tumors. Data were presented at the American Society of Clinical Oncology Annual Meeting in Chicago, IL.

Podcast: ‘What the Health?' health plans busting out all over

In a busy health week for Congress, Republicans and Democrats on the Senate Finance Committee agreed on a proposal to fund the Children's Health Insurance Program for five more years, while Republicans and Democrats at the Health, Education, Labor, and Pensions Committee continued to pursue a joint plan to stabilize the individual health insurance market.

Read more Medical News

› Verified 9 days ago